Stuart Kirby - Silo Wellness VP Communications
| SILFFDelisted Stock | USD 0.01 0.00 0.00% |
Insider
Stuart Kirby is VP Communications of Silo Wellness
| Phone | 416 861 2262 |
| Web | https://www.silowellness.com |
Silo Wellness Management Efficiency
The company has return on total asset (ROA) of (3.9555) % which means that it has lost $3.9555 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (4.3346) %, meaning that it generated substantial loss on money invested by shareholders. Silo Wellness' management efficiency ratios could be used to measure how well Silo Wellness manages its routine affairs as well as how well it operates its assets and liabilities.Silo Wellness has accumulated 2.17 M in total debt with debt to equity ratio (D/E) of 0.08, which may suggest the company is not taking enough advantage from borrowing. Silo Wellness has a current ratio of 0.08, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Silo Wellness until it has trouble settling it off, either with new capital or with free cash flow. So, Silo Wellness' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Silo Wellness sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Silo to invest in growth at high rates of return. When we think about Silo Wellness' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| France Landry | Cannara Biotech | N/A | |
| Ivana Maric | Avicanna | N/A | |
| Alexander Wolfe | Cannara Biotech | N/A | |
| Brian Sherman | Cannara Biotech | N/A | |
| Julia Bouvet | Cannara Biotech | N/A | |
| Scott Landers | Grey Cloak Tech | N/A | |
| MD FAAN | Eisai Co | 73 | |
| Anthony Manouk | Cannara Biotech | N/A | |
| Yosuke Akita | Eisai Co | 58 | |
| Nadeem Sarwar | Eisai Co | N/A | |
| Teruyuki Masaka | Eisai Co | 45 | |
| Kevin Pitts | Grey Cloak Tech | 63 | |
| Mba BEcon | Avicanna | N/A | |
| Carlos Muete | Avicanna | N/A | |
| Frantz Devedec | Avicanna | N/A | |
| Etienne Ledoux | Cannara Biotech | N/A | |
| Roland Alvarez | Avicanna | N/A | |
| David Abitbol | Cannara Biotech | N/A | |
| Avi Krivorot | Cannara Biotech | N/A | |
| Caitlin Johnston | Avicanna | N/A | |
| Robert Madden | Grey Cloak Tech | 51 | |
Management Performance
| Return On Equity | -4.33 | |||
| Return On Asset | -3.96 |
Silo Wellness Management Team
Elected by the shareholders, the Silo Wellness' board of directors comprises two types of representatives: Silo Wellness inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Silo. The board's role is to monitor Silo Wellness' management team and ensure that shareholders' interests are well served. Silo Wellness' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Silo Wellness' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mike Arnold, Interim Founder | ||
| Stuart Kirby, VP Communications | ||
| BA CA, CFO Director |
Silo Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Silo Wellness a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -4.33 | |||
| Return On Asset | -3.96 | |||
| Operating Margin | (10.13) % | |||
| Current Valuation | 2.04 M | |||
| Shares Outstanding | 6.03 M | |||
| Shares Owned By Insiders | 1.34 % | |||
| Price To Sales | 0.17 X | |||
| Revenue | 120.12 K | |||
| Gross Profit | (268.49 K) | |||
| EBITDA | (6.09 M) |
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in Silo Pink Sheet
If you are still planning to invest in Silo Wellness check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Silo Wellness' history and understand the potential risks before investing.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |